Cargando…

Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey

BACKGROUND: People over age 50–55 have historically been excluded from randomized clinical trials for multiple sclerosis (MS). However, more than half of those living with an MS diagnosis are over 55. OBJECTIVE: Explore the unique considerations of treating older people with MS (PwMS) using an itera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tumani, Hayrettin, Coyle, Patricia K, Cárcamo, Claudia, Cordioli, Cinzia, López, Pablo A, Peterka, Marek, Ramo-Tello, Cristina, Zuluaga, María I, Koster, Thijs, Vignos, Megan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501080/ https://www.ncbi.nlm.nih.gov/pubmed/37720692 http://dx.doi.org/10.1177/20552173231198588

Ejemplares similares

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Correction to: Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

The TRACK-MS Test Battery: A Very Brief Tool to Track Multiple Sclerosis-Related Cognitive Impairment
por: Taranu, Daniela, et al.
Publicado: (2022)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023)

Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report
por: Rapp, Daniel, et al.
Publicado: (2020)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis—Report of Two Cases
por: Rau, Daniela, et al.
Publicado: (2015)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Development and Validation of an Ultrasensitive Procalcitonin Sandwich Immunoassay
por: Carcamo Yañez, Viviana A., et al.
Publicado: (2017)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

Cerebrospinal fluid–related tissue damage in multiple sclerosis patients with iron rim lesions
por: Wittayer, Matthias, et al.
Publicado: (2023)

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
por: Konen, Franz Felix, et al.
Publicado: (2021)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
por: Huss, André, et al.
Publicado: (2020)

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
por: Brettschneider, Johannes, et al.
Publicado: (2009)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
por: Ortega-Hernandez, Oscar-Danilo, et al.
Publicado: (2023)

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis
por: Thomas, Katja, et al.
Publicado: (2014)

Differential Expression of Serum Extracellular Vesicle miRNAs in Multiple Sclerosis: Disease-Stage Specificity and Relevance to Pathophysiology
por: Cuomo-Haymour, Nagiua, et al.
Publicado: (2022)

Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
por: Linker, Ralf A., et al.
Publicado: (2009)

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
por: Dörr, Jan, et al.
Publicado: (2018)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
por: Dorst, Johannes, et al.
Publicado: (2019)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
por: Dorst, Johannes, et al.
Publicado: (2020)

Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
por: Hegen, Harald, et al.
Publicado: (2022)

The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
por: Castellazzi, Massimiliano, et al.
Publicado: (2022)

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Automated Analysis of Cerebrospinal Fluid Cells Using Commercially Available Blood Cell Analysis Devices—A Critical Appraisal
por: Wick, Manfred, et al.
Publicado: (2021)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
por: Brauchle, Felix, et al.
Publicado: (2023)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

The Definition of Paramedicine: An International Delphi Study
por: Williams, Brett, et al.
Publicado: (2021)

The special role of CXCL13 in Lyme neuroborreliosis: a case report
por: Erhart, Deborah K., et al.
Publicado: (2022)

Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece
por: Charonis, Aristidis S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ephf7ihiq9no9qft6b66s3l467